Almost a month after the start of the campaign for the second booster vaccination against Covid-19 only 6% of the population have made use of the offer.
This content was published on
1 minute
Keystone-SDA/ts
Português
pt
Mais de 30% dos suíços permanecem não vacinados contra a Covid
Since October 10 the authorities have recorded around 344,000 second booster vaccinations.
In total, around 535,000 people in Switzerland and Liechtenstein have received a second booster vaccination, the Federal Office of Public Health (FOPH) said on Tuesday, confirming a report by Swiss public radio, SRF.
By the end of October at least one vaccination dose had been given to 69.7% of the population.
More
More
Covid-19 booster shots available to Swiss residents
This content was published on
The authorities recommend that people aged over 16, especially the most vulnerable, get a booster shot to contain a new wave of infections.
In the past six months, 697,398 people – just under 8% of the population – received a jab. It is not possible to determine from the FOPH figures what proportion of this was a booster vaccination.
However, almost a quarter (23.4%) of people in the over-65 risk group have been vaccinated in the past six months. In this age group, 90.1% of the population have been vaccinated at least once. Among 16- to 64-year-olds, the proportion of those vaccinated in the past six months was 5.2%.
More than 13,700 people have died in Switzerland, which has a population of 8.7 million, in connection with Covid-19.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
EU Commission president says Swiss-EU deal is ‘historic’ agreement
This content was published on
At a joint media conference with Swiss President Viola Amherd in Bern, European Commission President Ursula von der Leyen spoke of a "day of joy".
Switzerland and EU reach deal on future bilateral relations
This content was published on
Switzerland and the European Union have announced a political agreement to update their trading relationship after almost a decade of difficult talks.
Swiss government recommends Covid booster from mid-October
This content was published on
The Swiss authorities have recommended that people aged over 16, especially the most vulnerable, get a Covid-19 booster shot.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.